FIELD: biotechnology.
SUBSTANCE: invention relates to the biotechnology. Described is a polypeptide for targeting the released phosphatidylserine (PtdS) of a cell membrane, which involves: (a) protein S gamma-carboxyglutamic acid domain presented in SEQ ID NO: 1, or a sequence which is at least 95 % homologous to it, which does not contain a protease domain or a hormone-binding domain; and (b) S EGF domain protein.
EFFECT: invention can be used for treating cancer, viral disease, autoimmune disease, hypercoagulation disorder, sepsis, vascular-occlusive crisis.
26 cl, 8 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| GLA DOMAINS AS TARGETING AGENTS | 2014 |
|
RU2731507C1 |
| GLA DOMAINS AS TARGETING AGENTS | 2014 |
|
RU2711091C2 |
| FACTOR VII CHIMERIC MOLECULES | 2010 |
|
RU2563231C2 |
| USEFUL LOAD DELIVERY TO STEM CELLS | 2018 |
|
RU2795155C1 |
| METHOD FOR TARGETED IMPACT ON EXOSOMES | 2018 |
|
RU2781640C2 |
| MODIFIED VITAMIN K DEPENDENT POLYPEPTIDES | 2005 |
|
RU2396347C2 |
| MODIFIED FACTOR VII-BASED POLYPEPTIDES AND THEREOF APPLICATION | 2008 |
|
RU2571931C2 |
| METHOD FOR ESTIMATING RISK OF DEVELOPMENT AND PROPENSITY FOR PATHOLOGY ASSOCIATED WITH EPCR AUTOANTIBODIES OBSERVED | 2005 |
|
RU2375716C2 |
| MODIFIED COAGULATION FACTOR VIIa WITH EXTENDED HALF-LIFE | 2007 |
|
RU2466141C2 |
| EUKARYOTIC HOST CELL FOR EXPRESSION VITAMIN K DEPENDENT PROTEIN, EXPRESSION VECTOR IN EUKARYOTIC CELLS, METHOD FOR MAKING GAMMA-CARBOXYLATED VITAMIN K DEPENDENT PROTEIN AND METHOD FOR MAKING PHARMACEUTICAL COMPOSITION FOR COAGULATION INDUCTION OR STIMULATION OF COAGULATION INCREASE OR DECREASE | 2004 |
|
RU2372401C2 |
